Kayothera
  • Science
  • Team
  • Investors
  • News
  • Contact
Select Page
Kayothera, Inc. and Columbia University Announce Publication in Nature Communications Detailing Novel Therapeutic Strategy for Type 2 Diabetes

Kayothera, Inc. and Columbia University Announce Publication in Nature Communications Detailing Novel Therapeutic Strategy for Type 2 Diabetes

Feb 2, 2023 | News, Press Release

Seattle, WA — February 02, 2023,  A paper published today in the peer-reviewed journal Nature Communications, co-authored by researchers from Columbia University, Kayothera, Inc., and Princeton University, describes a new therapeutic strategy for treatment of type 2...
Kayothera, Inc. and Columbia University Announce Publication in Nature Communications Detailing Novel Therapeutic Strategy for Type 2 Diabetes

KayoThera, Inc. Raises $8 Million in Series A Financing Led by Accelerator Life Science Partners to Develop Novel Cancer Immunotherapeutics

Mar 16, 2022 | News, Press Release

Novel Approach to Treat Late-Stage and Metastatic Cancers SEATTLE, WA – March 16, 2022, KayoThera, Inc. (“KayoThera”), an early-stage therapeutics company developing novel cancer immunotherapies, today announces the closing of an $8 million Series A round of...
Next Entries »

Categories

  • Events (2)
  • News (22)
  • Press Release (8)
  • Contact
    © 2024 KAYOTHERA® — All Rights Reserved